![](https://www.dovepress.com/assets/img/addon/og_logo.png)
Tolerability of Current Treatments for Dry Eye Disease: A Review of Approved and Investigational Therapies
Introduction Dry eye disease (DED), or keratoconjunctivitis sicca, is a common, multifactorial ocular disease impacting between 5% and 20% of people in Western countries and between 45% and 70% of people in Asian countries.1,2 The pathophysiology of DED …